Placenta
Volume 30, Issue 5 , Pages 424-433 , May 2009

Differential Placental Gene Expression in Severe Preeclampsia

  • V. Sitras

      Affiliations

    • Department of Obstetrics and Gynecology, University Hospital of Northern Norway and Institute of Clinical Medicine, University of Tromsø, PO Box 24, N-9038 Tromsø, Norway
    • Corresponding Author InformationCorresponding author. Tel.: +47 776 26 000; fax: +47 776 26 421.
    • These authors contributed equally to this work.
    • ,
  • R.H. Paulssen

      Affiliations

    • Laboratory of Molecular Medical Research, Institute of Clinical Medicine, University of Tromsø, N-9037, Norway
    • These authors contributed equally to this work.
    • ,
  • H. Grønaas

      Affiliations

    • Department of Medical Genetics, University Hospital of Northern Norway, N-9038, Norway
    • Present address: WesternGeco, Oslo Technology Center, Schlumberger House, N-1372 Asker, Norway.
    • ,
  • J. Leirvik

      Affiliations

    • Department of Medical Genetics, University Hospital of Northern Norway, N-9038, Norway
    • ,
  • T.A. Hanssen

      Affiliations

    • Department of Pathology, University Hospital of Northern Norway, N-9038, Norway
    • ,
  • Å. Vårtun

      Affiliations

    • Department of Obstetrics and Gynecology, University Hospital of Northern Norway and Institute of Clinical Medicine, University of Tromsø, PO Box 24, N-9038 Tromsø, Norway
    • ,
  • G. Acharya

      Affiliations

    • Department of Obstetrics and Gynecology, University Hospital of Northern Norway and Institute of Clinical Medicine, University of Tromsø, PO Box 24, N-9038 Tromsø, Norway

,Accepted 28 January 2009.

References 

  1. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005;26:785–799
  2. Oudejans CBM, van Dijk M. Placental gene expression and pre-eclampsia. Placenta. 2008;29:78–82
  3. Skjaerven R, Vatten LJ, Wilcox AJ, Ronning T, Irgens LM, Lie RT. Recurrence of pre-eclampsia across generations: exploring fetal and maternal genetic components in a population based cohort. BMJ. 2005;331:877–881
  4. Laivuori H. Genetic aspects of preeclampsia. Front Biosci. 2007;12:2372–2382
  5. Gauster M, Hiden U, Blaschitz A, Frank S, Lang U, Alvino G, et al. Dysregulation of placental endothelial lipase and lipoprotein lipase in intrauterine growth-restricted pregnancies. J Clin Endocrinol Metab. 2007;92:2256–2263
  6. Sitras V, Paulssen RH, Gronaas H, Vartun A, Acharya G. Gene expression profile in labouring and non-labouring human placenta near term. Mol Hum Reprod. 2008;14:61–65
  7. Founds SA, Dorman JS, Conley YP. Microarray technology applied to the complex disorder of preeclampsia. J Obstet Gynecol Neonatal Nurs. 2008;37:146–157
  8. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005;308:1592–1594
  9. Egbor M, Ansari T, Morris N, Green CJ, Sibbons PD. Morphometric placental villous and vascular abnormalities in early- and late-onset pre-eclampsia with and without fetal growth restriction. BJOG. 2006;113:580–589
  10. Acharya G, Sitras V, Erkinaro T, Makikallio K, Kavasmaa T, Pakkila M, et al. Experimental validation of uterine artery volume blood flow measurement by Doppler ultrasonography in pregnant sheep. Ultrasound Obstet Gynecol. 2007;29:401–406
  11. Sood R, Zehnder JL, Druzin ML, Brown PO. Gene expression patterns in human placenta. Proc Natl Acad Sci U S A. 2006;103:5478–5483
  12. Redline RW. Inflammatory responses in the placenta and umbilical cord. Semin Fetal Neonatal Med. 2006;11:296–301
  13. Skjaerven R, Wilcox AJ, Lie RT. The interval between pregnancies and the risk of preeclampsia. N Engl J Med. 2002;346:33–38
  14. Smyth GK. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004;3:Article 3
  15. Smyth GK. Limma: linear models for microarray data. In: Bioinformatics and computational biology solutions. 2000;p. 397–420
  16. Tibshirani R, Hastie T, Narasimhan B, Chu G. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci U S A. 2002;99:6567–6572
  17. Mootha V, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003;34:267–273
  18. Clark A, Glanowski S, Nielsen R, Thomas P, Kejariwal A, Todd M, et al. Inferring nonneutral evolution from human-chimp-mouse orthologous gene trios. Science. 2003;302:1960–1963
  19. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29:e45
  20. Ajubi NE, Nijholt N, Wolthuis A. Quantitative automated human chorionic gonadotropin measurement in urine using the Modular Analytics E170 module (Roche). Clin Chem Lab Med. 2005;43:68–70
  21. Raychaunhuri A, Stuart JM, Altman RB. Principal component analysis to summarize microarray experiments: application to sporulation time series. Pac Symp Biocomput. 2000;5:452–463
  22. Tjoa ML, Levine RJ, Karumanchi SA. Angiogenic factors and preeclampsia. Front Biosci. 2007;12:2395–2402
  23. Li H, Fredriksson L, Li X, Eriksson U. PDGF-D is a potent transforming and angiogenic growth factor. Oncogene. 2003;22:1501–1510
  24. Reisinger K, Baal N, McKinnon T, Munstedt K, Zygmunt M. The gonadotropins: tissue-specific angiogenic factors?. Mol Cell Endocrinol. 2007;269:65–80
  25. Prast J, Saleh L, Husslein H, Sonderegger S, Helmer H, Knofler M. Human chorionic gonadotropin stimulates trophoblast invasion through extracellularly regulated kinase and AKT signaling. Endocrinology. 2008;149:979–987
  26. Bartha JL, Romero-Carmona R, Escobar-Llompart M, Paloma-Castro O, Comino-Delgado R. Human chorionic gonadotropin and vascular endothelial growth factor in normal and complicated pregnancies. Obstet Gynecol. 2003;102:995–999
  27. Said ME, Campbell DM, Azzam ME, MacGillivray I. Beta-human chorionic gonadotrophin levels before and after the development of pre-eclampsia. Br J Obstet Gynaecol. 1984;91:772–775
  28. Ashour AM, Lieberman ES, Haug LE, Repke JT. The value of elevated second-trimester beta-human chorionic gonadotropin in predicting development of preeclampsia. Am J Obstet Gynecol. 1997;176:438–442
  29. Luckas M, Hawe J, Meekins J, Neilson J, Walkinshaw S. Second trimester serum free beta human chorionic gonadotrophin levels as a predictor of pre-eclampsia. Acta Obstet Gynecol Scand. 1998;77:381–384
  30. Wehmann RE, Nisula BC. Metabolic and renal clearance rates of purified human chorionic gonadotropin. J Clin Invest. 1981;68:184–194
  31. Bahado-Singh RO, Oz U, Isozaki T, Seli E, Kovanci E, Hsu CD, et al. Midtrimester urine human chorionic gonadotropin beta-subunit core fragment levels and the subsequent development of pre-eclampsia. Am J Obstet Gynecol. 1998;179:738–741
  32. Lu D, Yang X, Wu Y, Wang H, Huang H, Dong M. Serum adiponectin, leptin and soluble leptin receptor in pre-eclampsia. Int J Gynaecol Obstet. 2006;95:121–126
  33. White V, Gonzalez E, Capobianco E, Pustovrh C, Martinez N, Higa R, et al. Leptin modulates nitric oxide production and lipid metabolism in human placenta. Reprod Fertil Dev. 2006;18:425–432
  34. Magarinos MP, Sanchez-Margalet V, Kotler M, Calvo JC, Varone CL. Leptin promotes cell proliferation and survival of trophoblastic cells. Biol Reprod. 2007;76:203–210
  35. Schroeter MR, Leifheit M, Sudholt P, Heida NM, Dellas C, Rohm I, et al. Leptin enhances the recruitment of endothelial progenitor cells into neointimal lesions after vascular injury by promoting integrin-mediated adhesion. Circ Res. 2008;103:536–544
  36. Islami D, Bischof P, Chardonnens D. Possible interactions between leptin, gonadotrophin-releasing hormone (GnRH-I and II) and human chorionic gonadotrophin. Eur J Obstet Gynecol Reprod Biol. 2003;110:169–175
  37. Di Santo S, Malek A, Sager R, Andres AC, Schneider H. Trophoblast viability in perfused term placental tissue and explant cultures limited to 7–24hours. Placenta. 2003;24:882–884
  38. Nishizawa H, Pryor-Koishi K, Kato T, Kowa H, Kurahashi H, Udagawa Y. Microarray analysis of differentially expressed fetal genes in placental tissue derived from early and late onset severe pre-eclampsia. Placenta. 2007;28:487–497
  39. Fujiwara H, Higuchi T, Yamada S, Hirano T, Sato Y, Nishioka Y, et al. Human extravillous trophoblasts express laeverin, a novel protein that belongs to membrane-bound gluzincin metallopeptidases. Biochem Biophys Res Commun. 2004;313:962–968
  40. Fujiwara H. Membrane-bound peptidases regulate human extravillous trophoblast invasion. Placenta. 2007;28:70–75
  41. Petrovic N, Schacke W, Gahagan JR, O'Conor CA, Winnicka B, Conway RE, et al. CD13/APN regulates endothelial invasion and filopodia formation. Blood. 2007;110:142–150
  42. Rehman AO, Wang CY. Notch signaling in the regulation of tumor angiogenesis. Trends Cell Biol. 2006;16:293–300
  43. Gridley T. Notch signaling in vascular development and physiology. Development. 2007;134:2709–2718
  44. Krebs LT, Xue Y, Norton CR, Shutter JR, Maguire M, Sundberg JP, et al. Notch signaling is essential for vascular morphogenesis in mice. Genes Dev. 2000;14:1343–1352
  45. Lawson ND, Vogel AM, Weinstein BM. Sonic hedgehog and vascular endothelial growth factor act upstream of the Notch pathway during arterial endothelial differentiation. Dev Cell. 2002;3:127–136
  46. Kalaria RN, Viitanen M, Kalimo H, Dichgans M, Tabira T. The pathogenesis of CADASIL: an update. J Neurol Sci. 2004;226:35–39
  47. Masaki T, Miwa S, Sawamura T, Ninomiya H, Okamoto Y. Subcellular mechanisms of endothelin action in vascular system. Eur J Pharmacol. 1999;375:133–138

PII: S0143-4004(09)00033-2

doi: 10.1016/j.placenta.2009.01.012

Placenta
Volume 30, Issue 5 , Pages 424-433 , May 2009

Article Tools

* Image Usage & Resolution